AI-generated from publicly available materials.A recent study involving over 5,400 cancer patients has revealed that Daymark Health's supportive oncology program, which integrates telemedicine and in-home care, significantly reduces hospital admissions and healthcare costs.
The study, conducted across 20 oncology practices, found that patients enrolled in this program experienced a 10.4% decrease in hospital admissions and an 8.1% reduction in overall healthcare spending. Launched in collaboration with Blue Cross & Blue Shield of Rhode Island, the program emphasizes proactive care, symptom management, and mental health support, aiming to address issues before they escalate into emergencies. The findings suggest a monthly savings of approximately $789 per patient compared to expected costs based on historical data.
Dr. Angela Taber, the medical director at Daymark Health, highlighted that the program is designed to complement oncologists' efforts rather than replace them. By ensuring seamless communication and sharing of patient information, the program enhances the overall quality of cancer care. The integration of technology allows for real-time monitoring, enabling timely interventions that can prevent hospitalizations.
Despite the promising results, the study's observational nature raises questions about causation. Dr. Taber emphasized the importance of ongoing evaluation and the need for comprehensive datasets to strengthen future research. The study also points to significant barriers, particularly in payment models, that hinder the broader adoption of such proactive care approaches in oncology. Transitioning to value-based care could ultimately lead to better outcomes for patients and more efficient healthcare systems.